Myasthenia Gravis Awareness Month

Myasthenia Gravis Awareness Month

It is estimated that nearly 700,000 people suffer from Myasthenia Gravis (MG), worldwide. Research has shown that MG is more prevalent in women than in men. If a woman has MG, she can expect to start seeing symptoms of this autoimmune disease in her 20s or 30s, while men may not start seeing symptoms until their 50s or 60s.1 

What is Myasthenia Gravis?

Myasthenia gravis is a chronic autoimmune, neuromuscular disease that causes weakness in the skeletal muscles that worsens after periods of activity and improves after periods of rest. These muscles are responsible for functions involving breathing and moving parts of the body, including the arms and legs.2

Symptoms of MG may include: 

  • Weakness in arm & leg muscles
  • Double vision
  • Drooping of upper eyelids
  • Difficulty with speech
  • Difficulty chewing
  • Fatigue
  • Shortness of breath

June is Myasthenia Gravis Awareness Month. If you, a family member or a friend suffers from MG, just know you are not alone. We encourage those reading this article to further learn about MG by visiting the following websites:

  1. American Association of Neuromuscular & Electrodiagnostic Medicine
  2. Myasthenia Gravis Foundation of America
  3. Premier Neurology & Wellness Center


How can Redline Specialty Pharmacy help those with MG?

As an accredited specialty and home infusion pharmacy, we can provide medications and nursing support for those suffering from MG.  As a specialty infusion pharmacy, we can provide treatments for patients who have not responded to first-line therapies like cholinesterase inhibitors, corticosteroids or other immunosuppressants or if you have sudden worsening of symptoms. Some of these second-line treatments include monoclonal antibodies (Rituxan, Soliris) or immunoglobulin (IVIg) therapy.  


Redline Specialty Pharmacy is an ACHC and PCAB accredited home infusion and compounding pharmacy in Hastings, Nebraska. We serve patients with complex medical conditions and are licensed in Nebraska, Kansas, Colorado, Iowa and South Dakota.